Skip to main content
Clinical Trials/IRCT20190222042805N1
IRCT20190222042805N1
Completed
Phase 3

Effect of Intravenous Dexmedetomidine on Post-Operative Pain in Patients undergoing Total Abdominal Hysterectomy

Ahvaz University of Medical Sciences0 sites70 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Ahvaz University of Medical Sciences
Enrollment
70
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Female candidate of Total Abdominal Hysterectomy (TAH)
  • Age range 35–65 years
  • Body mass index (BMI): 18 to 40 kg/m2
  • American Society of Anesthesiologists (ASA) classification I , II

Exclusion Criteria

  • Allergic reaction to Dexmedetomidine
  • History of Dexmedetomidine administration over the past week
  • History of heart, lung, liver, and kidney diseases
  • Patients with neurological or neuromuscular disorders
  • Patients with anemia or bleeding disorders
  • Patients with anemia or bleeding disorders Consumption of Alcohol, narcotic and Antipsychotic medications
  • Patients with diabetes

Outcomes

Primary Outcomes

Not specified

Similar Trials